Senate Bill sb0402c1
CODING: Words stricken are deletions; words underlined are additions.
Florida Senate - 2002 CS for SB 402
By the Committee on Health, Aging and Long-Term Care; and
Senator Campbell
317-835-02
1 A bill to be entitled
2 An act relating to pharmacy; providing a short
3 title; defining the term "pharmaceutical
4 adverse incident" and requiring that such
5 incidents be reported to the Department of
6 Health; providing exceptions; requiring the
7 department to review reported incidents to
8 determine whether the incidents potentially
9 involve conduct by a health care practitioner
10 that is subject to disciplinary action;
11 specifying that any disciplinary action shall
12 be taken by the appropriate board; providing
13 for the adoption of rules and forms; providing
14 effective dates.
15
16 Be It Enacted by the Legislature of the State of Florida:
17
18 Section 1. This act may be cited as the "Ernest Belles
19 Act."
20 Section 2. (1) As used in this section, the term
21 "pharmaceutical adverse incident" means the dispensing of a
22 different medication, a different dose, or the correct
23 medication in a container with different instructions than
24 those specified in the prescription, which dispensation
25 results in actual harm to a patient, but does not include the
26 dispensing of a generic equivalent medication with the
27 patient's consent.
28 (2) A pharmacist licensed under chapter 465, Florida
29 Statutes, or other health care practitioner as defined in
30 section 456.001, Florida Statutes, who becomes aware of a
31 patient's allegation that a pharmaceutical adverse incident
1
CODING: Words stricken are deletions; words underlined are additions.
Florida Senate - 2002 CS for SB 402
317-835-02
1 has occurred which was caused by a health care practitioner,
2 must report such allegation to the Department of Health on
3 forms provided by the department. This section does not apply
4 to:
5 (a) Pharmacists employed by pharmacies that
6 participate in the program provided by Rule 64B16-27.300,
7 Florida Administrative Code; or
8 (b) Pharmacists employed by pharmacies that have
9 notified the Board of Pharmacy that they will establish a
10 continuous quality-improvement program consistent with the
11 requirements of Rule 64B16-27.300, Florida Administrative
12 Code.
13 (3) The required notification to the department must
14 be submitted in writing by certified mail and postmarked
15 within 15 days after the pharmacist or health care
16 practitioner became aware of the patient's allegation that a
17 pharmaceutical adverse incident has occurred.
18 (4) Effective July 1, 2004, subject to subsequent act
19 of the Legislature and a specific appropriation sufficient to
20 cover the actual costs, the department shall review each
21 incident and determine whether it potentially involved conduct
22 by a pharmacist or health care practitioner who is subject to
23 disciplinary action, in which case section 465.073, Florida
24 Statutes, applies. Disciplinary action, if any, shall be
25 taken by the board under which the pharmacist or health care
26 practitioner is licensed.
27 (5) The Department of Health shall adopt forms and
28 rules for administering this section.
29 Section 3. Section 2 of this act shall take effect
30 only upon the effective date of legislation that makes any
31 such information provided to the Department of Health
2
CODING: Words stricken are deletions; words underlined are additions.
Florida Senate - 2002 CS for SB 402
317-835-02
1 confidential and exempt from section 119.07(1), Florida
2 Statutes, and Section 24(a) of Article I of the State
3 Constitution, until 10 days after probable cause is found that
4 a violation of law occurred. Such legislation must also
5 provide that information may be used by the department or the
6 Board of Pharmacy only in a disciplinary proceeding brought
7 against the pharmacist or by the department in any study of
8 adverse incidents without identifying the patient, pharmacist,
9 pharmacy, office, or entity by name, location, or other
10 identifier.
11 Section 4. Except as otherwise expressly provided in
12 this act, this act shall take effect July 1, 2002.
13
14 STATEMENT OF SUBSTANTIAL CHANGES CONTAINED IN
COMMITTEE SUBSTITUTE FOR
15 Senate Bill 402
16
17 The Committee Substitute for Senate Bill 402 clarifies that
licensed pharmacists and other health care practitioners as
18 defined in s. 456.001, F.S., who become aware of a patient's
allegation of a pharmaceutical adverse incident must report
19 such allegation rather than the actual incident, itself, to
the Department of Health. The notification must be submitted
20 in writing by certified mail and postmarked within 15 days
after the pharmacist or health care practitioner became aware
21 of the patient's allegation that a pharmaceutical adverse
incident has occurred.
22
23
24
25
26
27
28
29
30
31
3
CODING: Words stricken are deletions; words underlined are additions.